Cost-effectiveness of therapeutic drug monitoring in inflammatory bowel disease
Richard McNeill, Murray L. Barclay
Topics & Concepts
MedicineTherapeutic drug monitoringVedolizumabInflammatory bowel diseaseIntensive care medicinePharmacotherapyMethotrexateDrugCost effectivenessDiseaseUlcerative colitisInflammatory Bowel DiseasesPharmacologyInternal medicineRisk analysis (engineering)Inflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsMicroscopic Colitis